Name (Synonyms) | Correlation | |
---|---|---|
drug678 | Clevudine Wiki | 1.00 |
drug2122 | Placebo Wiki | 0.05 |
There is one clinical trial.
Novel coronavirus disease 19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), this pneumonia was first emerged in December 2019 in Wuhan, China and rapidly spread around the world . Coagulopathy is one of the most significant prognostic factors in patients with COVID-19 and is associated with increased mortality and admission to critical care. Most observed coagulopathy in patients hospitalized with COVID-19 (COVID-19-associated coagulopathy) is characterized by increased D-dimer and fibrinogen levels. 71% of patients who did not survive hospitalization reported to have developed disseminated intravascular coagulation
Description: measuring how rapid the sample will get clotted
Measure: clot rate formation Time: 30 minutes